iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data 26-10-2023, 15:00

The 3rd Edition Of The 2025 Vietnam ESG Investor Conference Drives Actionable Commitments To Sustainable Growth And Net-Zero Goals 16-05-2025, 15:36

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection 22-10-2024, 19:00